Adjuvants that enhance priming of cytotoxic T cells to a Kb-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen

International Immunology

Volumn 11, Issue 7, 1999, Pages 1093-1102

  Schirmbeck, Reinhold ^a   Melber, Karl ^b   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

^b Rhein Biotech GmbH   (Germany)

Author keywords

Cytotoxic T lymphocyte; Hepatitis B surface antigen; MHC class I; Mouse

Indexed keywords

EPITOPE; HEPATITIS B SURFACE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OLIGODEOXYNUCLEOTIDE; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA SEQUENCE; FEMALE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; CYTOKINES; EPITOPES, T-LYMPHOCYTE; FEMALE; H-2 ANTIGENS; HEPATITIS B SURFACE ANTIGENS; INJECTIONS, INTRAMUSCULAR; INTERLEUKIN-12; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS;

EID: 0032769413     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.7.1093     Document Type: Article

References (60)

1. Schirmbeck, R., Melber, K., Mertens, T. and Reimann, J. 1994. Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis. J. Virol. 68:1418.
2. + cytotoxic T lymphocyte responses in vivo. J. Immunol. 152:1110.
3. Schirmbeck, R., Melber, K., Mertens, T. and Reimann, J. 1994. Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen. Eur. J. Immunol. 24:1088.
4. Böhm, W., Schirmbeck, R., Elbe, A., Melber, K., Diminsky, D., Kraal, G., Van Rooijen, N., Barenholz, Y. and Reimann, J. 1995. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. J. Immunol. 155:3313.
5. Schirmbeck, R., Böhm, W., Ando, K.-I., Chisari, F. V. and Reimann, J. 1995. Nucleic acid vaccination primes hepatitis B surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 69:5929.
6. Davis, H. L., Schirmbeck, R., Reimann, J. and Whalen, R. G. 1995. DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to Hepatitis B virus surface antigen. Hum. Gene Ther. 6:1447.
7. Böhm, W., Kuhröber, A., Paier, T., Mertens, T., Reimann, J. and Schirmbeck, R. 1996. DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocytes and antibody responses in mice after intramuscular injection. J. Immunol. Methods 193:29.
8. Schirmbeck, R., Melber, K. and Reimann, J. 1995. Hepatitis B virus surface particles are processed in a novel endosomal pathway for MHC class I-restricted epitope presentation. Eur. J. Immunol. 25:1063.
9. Schirmbeck, R., Böhm, W., Melber, K. and Reimann, J. 1995. Processing of exogenous heat-aggregated (denatured) or particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. J. Immunol. 155:4676.
10. d molecules capture peptides from endocytosed, exogenous antigens for MHC class I-restricted presentation. Eur. J. Immunol. 26:2812.
11. 2m. Eur. J. Immunol. 27:3471.
12. Davis, H. L., Weeranta, R., Waldschmidt, T. J., Tygrett, L., Schorr, J. and Krieg, A. M. 1998. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160:870.
13. McCluskey, J. and Davis, H. L. 1998. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J. Immunol. 161:4463.
14. Heemels, M. T. and Ploegh, H. L. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:463.
15. Lehner, P. J. and Cresswell, P. 1996. Processing and delivery of peptides presented by MHC class I molecules. Curr. Opin. Immunol. 8:59.
16. Ploegh, H. L, 1997. Destruction of proteins as a creative force. Immunol. Today 18:269.
17. Jondal, M., Schirmbeck, R. and Reimann, J. 1996. MHC class I-restricted CTL responses to exogenous antigens. Immunity 5:295.
18. Reimann, J. and Kaufmann, S. H. E. 1997. Alternate antigen processing pathways for the MHC I-restricted epitope presentation operate for activating protective T cell immunity. Curr. Opin. Immunol. 9:462.
19. Schirmbeck, R., Wild, J. and Reimann, J. 1998. Similar as well as distinct MHC I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen (HBsAg). Eur. J. Immunol. 28:4149.
20. Pisetsky, D. S. 1997. Immunostimulatory DNA: aclear and present danger? Nat. Med. 3:829.
21. Krieg, A. M. 1996. An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA. J. Lab. Clin. Med. 128:128.
22. Pisetsky, D. S. 1996. The immunologic properties of DNA. J. Immunol. 156:421.
23. Pisetsky, D. S. 1996. Immune activation by bacterial DNA: a new genetic code. Immunity 5:303.
24. + CTL responses in vitro. J. Clin. Invest. 98:715.
25. Pulaski, B. A., Yeh, K. Y., Shastri, N., Maltby, K. M., Penney, D. P., Lord, E. M. and Frelinger, J. G. 1996. Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex 're-presentation' of exogenous antigen by tumor-infiltrating antigen-presenting cells. Proc. Natl Acad. Sci. USA 93:3669.
26. Nicolet, C. M., Burkholder, J. K., Gan, J., Culp, J., Kashmiri, S. V., Schlom, J., Yang, N. S. and Sondel, P. M. 1995. Expression of a tumor-reactive antibody-interleukin 2 fusion protein after in vivo particle-mediated gene delivery. Cancer Gene Ther. 2:161.
27. Xiang, Z. Q. and Ertl, H. C. J. 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129.
28. Rakhmilevich, A. L., Turner, J., Ford, M. J., McCabe, D., Sun, W. H., Sondel, P. M., Grota, K. and Yang, N, S. 1996. Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc. Natl Acad. Sci. USA 93:6291.
29. Tan, J., Newton, C. A., Djeu, J. Y., Gutsch, D. E., Chang, A. E., Yang, N. S., Klein, T. W. and Hua, Y. 1996. Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model. Cancer Res. 56:3399.
30. Chow, Y. H., Huang, W. L., Chi, W. K., Chu, Y. D. and Tao, M. H. 1997. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 71:169.
31. Geissler, M., Gesien, A., Tokushige, K. and Wands, J. R. 1997. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 158:1231.
32. Kim, J. J., Ayyavoo, V., Bagarazzi, M. L., Chattergoon, M. A., Dang, K., Wang, B., Boyer, J. D. and Weiner, D. B. 1997. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:816.
33. Kim, T. S., DeKruyff, R. H., Rupper, R., Maecker, H. T., Levy, S. and Umetsu, D. T. 1997. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J. Immunol. 158:4137.
34. Okada, E., Sasaki, S., Ishii, N., Aoki, I., Yasuda, T., Nishioka, K., Fukushima, J., Miyazaki, J., Wahren, B. and Okuda, K. 1997. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159:3638.
35. Janowicz, Z. A., Melber, K., Merckelbach, A., Jacobs, E., Harford, N., Comberbach, M. and Hollenberg, C. P. 1991. Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast, Hansenula polymorpha. Yeast. 7:431.
36. Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M.-D., Silverman, G. J., Lotz, M., Carson, D. A., Raz, E. and Nguyen, M. D. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352.
37. Rammensee, H. G., Falk, K. and Rötzschke, O. 1993. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11:213.
38. Rammensee, H. G., Friede, T. and Stevanoviic, S. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
39. Berting, A., Hahnen, J., Kroger, M. and Gerlich, W. H. 1995. Computer-aided studies on the spatial structure of the small hepatitis B surface protein. Intervirology 38:8
40. Prange, R. and Streeck, R. E. 1995. Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO J. 14:247.
41. Lee, S. P., Thomas, W. A., Blake, N. W. and Rickinson, A. B. 1996. Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2. Eur. J. Immunol. 26:1875.
42. Krieg, A. M., Yi, A. K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A. and Klinman, D. M. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546.
43. Ballas, Z. K., Rasmussen, W. L. and Krieg, A. M. 1996. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157:1840.
44. Cowdery, J. S., Chace, J. H., Yi, A. K. and Krieg, A. M. 1996. Bacterial DNA induces NK cells to produce IFN-γ and increases the toxicity of lipopolysaccharides. J. Immunol. 156:4570.
45. Halpern, M. D., Kurlander, R. J. and Pisetsky, D. S. 1996. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α. Cell Immunol. 167:72.
46. Liang, H., Nishioka, Y., Reich, C. F., Pisetsky, D. S. and Lipsky, P. E. 1996. Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 98:1119.
47. Stacey, K. J., Sweet, M. J. and Hume, D. A. 1996. Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157:2116.
48. + T cells: Implications for tumor immunotherapy. Immunity 4:555.
49. Yi, A. K., Klinman, D. M., Martin, T. L., Matson, S. and Krieg, A. M. 1996. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J. Immunol. 157:5394.
50. Lipford, G. B., Bauer, M., Blank, C., Reiter, R., Wagner, H. and Heeg, K. 1997. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur. J. Immunol. 27:2340.
51. Roman, M., Martin, O. E., Goodman, J. S., Nguyen, M. D., Sato, Y., Ronaghy, A., Kornbluth, R. S., Richman, D. D., Carson, D. A. and Raz, E. 1997. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3:849.
52. Sparwasser, T., Miethke, T., Lipford, G., Erdmann, A., Hacker, H., Heeg, K. and Wagner, H. 1997. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-α-mediated shock. Eur. J. Immunol. 27:1671.
53. Sun, S., Beard, C., Jaenisch, R., Jones, P. and Sprent, J. 1997. Mitogenicity of DNA from different organisms for murine B cells. J. Immunol. 159:3119.
54. Sparwasser, T., Koch, E. S., Vabulas, R. M., Heeg, K., Lipford, G. B., Ellwart, J. W. and Wagner, H. 1998. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28:2045.
55. Jakob, T., Walker, P. S., Krieg, A. M., Udey, M. C. and Vogel, J. C. 1998. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th 1 responses by immunostimulatory DNA. J. Immunol. 161:3042.
56. h2 cells. Eur. J. Immunol. 23:1762.
57. Gajewski, T. F., Renauld, J. C., van Pel, A. and Boon, T. 1995. Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro. J. Immunol. 154:5637.
58. Eberl, G., Kessler, B., Eberl, L. P., Brunda, M. J., Valmori, D. and Corradin, G. 1996. Immunodominance of cytotoxic T lymphocyte epitopes co-injected in vivo and modulation by interleukin-12. Eur. J. Immunol. 26:2709.
59. Zitvogel, L., Robbins, P. D., Storkus, W. J., Clarke, M. R., Maeurer, M. J., Campbell, R. L., Davis, C. G., Tahara, H., Schreiber, R. D. and Lotze, M. T. 1996. Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors. Eur. J. Immunol. 26:1335.
60. + T cells. J. Immunol. 154:5071.